Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888-897.
Publication/Presentation Date
9-1-2023
Volume
46
Issue
9
First Page
1721
Last Page
1721
ISSN
1935-5548
Published In/Presented At
Rossing, P., Burgess, E., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Gillard, P., MacIsaac, R. J., Wainstein, J., Joseph, A., Brinker, M., Roessig, L., Scott, C., Bakris, G. L., & FIDELIO-DKD Investigators (2023). Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888-897. Diabetes care, 46(9), 1721. https://doi.org/10.2337/dc23-er09
Disciplines
Medicine and Health Sciences
PubMedID
37310695
Department(s)
Department of Medicine
Document Type
Article
COinS